Clinical trial
Early Focus II: A Prospective, Randomized, Controlled Trial to Test Safety and Effectiveness of Unilateral Exablate MR-guided Focused Ultrasound (MRgFUS) Subthalamotomy in Patients With Early-Stage Parkinson's Disease (ESPD)
NCT06584383 is registered in ClinicalTrials.gov with InSightec as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Focus II: A Prospective, Randomized, Controlled Trial to Test Safety and Effectiveness of Unilateral Exablate MR-guided Focused Ultrasound (MRgFUS) Subthalamotomy in Patients With Early-Stage Parkinson's Disease (ESPD)
- Lead sponsor
- InSightec
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 1, 2024
- Completion date
- September 30, 2029
- Enrollment
- 67 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.